Gmez, V
According to the MHRA-approved Summary of Product Characteristics (SmPC), the most commonly reported side effects include nausea, vomiting, diarrhoea, abdominal pain, and constipation
WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk
The nurse will call in the medication, and it will be delivered straight to your door each month
Correction to: clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Wellbutrin may begin to alleviate symptoms of depression within the first two weeks, but it can take up to six weeks to experience the full effect